Abstract
The Yellow Card scheme involves the collection of voluntary reports of suspected adverse drug reactions by health professionals. It is operated jointly by the Committee on the Safety of Medicines (CSM) and the Medicines and Healthcare products Regulatory Agency (MHRA). The purpose of the scheme is to increase the understanding of the safety profile of medicines and to ensure that any unrecognized adverse effects of medicines are identified as quickly as possible.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
